Sign up to save your podcasts
Or
Share JAMA Oncology : Survival and Adjuvant Chemotherapy in Early-Stage NSCLC With vs Without Clinicopathologic Features
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Oncology : Survival and Adjuvant Chemotherapy in Early-Stage NSCLC With vs Without Clinicopathologic Features
Interview with Daniel J Boffa, MD, author of Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non–Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Daniel J Boffa, MD, author of Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non–Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features
More shows like JAMA Network
View all
JAMA Editors' Summary
138 Listeners
NEJM This Week
322 Listeners
AFP: American Family Physician Podcast
702 Listeners
JAMA Clinical Reviews
498 Listeners
Medicine and Science from The BMJ
37 Listeners
Diabetes Core Update
102 Listeners
Mayo Clinic Talks
288 Listeners
The Curbsiders Internal Medicine Podcast
3,337 Listeners
JAMA Pediatrics Editors' Summary
38 Listeners
JAMA Neurology Author Interviews
13 Listeners
JAMA Dermatology Author Interviews
16 Listeners
JAMA Internal Medicine Author Interviews
18 Listeners
JAMA Otolaryngology–Head & Neck Surgery Author Interviews
6 Listeners
Core IM | Internal Medicine Podcast
1,154 Listeners
JAMAevidence The Rational Clinical Examination
30 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
88 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Cardionerds: A Cardiology Podcast
431 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
19 Listeners
The Curious Clinicians
370 Listeners
NEJM AI Grand Rounds
58 Listeners